Investing.com - Johnson & Johnson (NYSE:JNJ) posted fourth-quarter adjusted earnings and sales that topped analysts' estimates, as the pharmaceutical firm was boosted by demand for its cancer ...
W ouldn't it be great to sail through the rest of winter with soft skin? For the 78 percent of us bothered by itchy or sore ...